Form 4: Eli Lilly SVP Acquires Shares and Restricted Stock Units

Donald A. Zakrowski, SVP, Finance, & CAO of Eli Lilly & Co, reports acquisition of common stock and restricted stock units.

Summary

• On February 10, 2025, Donald A. Zakrowski, SVP, Finance, & CAO of Eli Lilly & Co, acquired 1,359.659 shares of common stock at a price of $868.88.
• Zakrowski also acquired 216.389 restricted stock units, each representing a contingent right to receive one share of Eli Lilly and Company common stock, exercisable on February 16, 2028, and expiring on February 16, 2028.
• Following the reported transactions, Zakrowski directly owns 6,839.659 shares of common stock and indirectly owns 1,718.42 shares through a 401(k).
• He also directly owns 216.389 restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard Form 4 filing reporting transactions by an officer. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.

Positives

• The acquisition of shares by a high-ranking executive could be interpreted as a positive signal about the executive's confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and are closely watched by investors for insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction could have a minor impact on shareholders as insider transactions are often monitored for sentiment.

Key Dates